[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100650003":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":23,"centralContacts":28,"locations":37,"responsibleParty":56,"collaborators":58,"id":61,"slug":62,"hasResults":63,"nctId":64,"briefTitle":65,"officialTitle":66,"acronym":67,"eligibilityCriteria":68,"healthyVolunteers":69,"sex":70,"minAge":71,"maxAge":72,"enrollmentInfo":73,"targetDuration":10,"studyType":76,"phases":10,"briefSummary":77,"conditions":78,"keywords":80,"overallStatus":40,"whyStopped":10,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":95},{"fullName":5,"class":6},"Royal Marsden NHS Foundation Trust","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Patient participants",null,"Diverse cohort of patients who have undergone genetic risk profiling and have received their results",[13],"Other: Qualitative interview",{"label":15,"type":10,"description":16,"interventionNames":17},"Provider participants","Healthcare providers who have delivered genetic risk profiling results to patients",[13],[19],{"type":6,"name":20,"description":21,"armGroupLabels":22,"otherNames":10},"Qualitative interview","Interview of participants to gain perspectives and experiences",[9,15],[24],{"name":25,"affiliation":26,"role":27},"Elizabeth Bancroft, RN PhD","The Royal Marsden NHS Foundation Trust \u002F The Institute of Cancer Research","PRINCIPAL_INVESTIGATOR",[29,34],{"name":30,"role":31,"phone":32,"phoneExt":10,"email":33},"Tarryn Shaw, MSc","CONTACT","020 8661 3375","tarryn.shaw@rmh.nhs.uk",{"name":25,"role":31,"phone":35,"phoneExt":10,"email":36},"02087224483","elizabeth.bancroft@rmh.nhs.uk",[38],{"facility":39,"status":40,"city":41,"state":10,"zip":42,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"The Royal Marsden Hospital (Sutton and Chelsea)","RECRUITING","London","SM2 5PT","United Kingdom","UK",{"type":46,"coordinates":47},"Point",[48,49],-0.12574,51.50853,{"lat":49,"lon":48},[52,55],{"name":53,"role":31,"phone":54,"phoneExt":10,"email":33},"Tarryn Shaw, MSc Genetic Counselling","0208 722 4483",{"name":25,"role":31,"phone":54,"phoneExt":10,"email":36},{"type":57,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[59],{"name":60,"class":6},"Institute of Cancer Research, United Kingdom","100650003","patient-and-provider-perspectives-on-genetic-risk-profiling-100650003",false,"NCT07741929","Patient and Provider Perspectives on Genetic Risk Profiling","Exploring the Patient and Provider Perspectives on the Utility of Genetic Risk Profiling for Prostate Cancer in Routine Clinical Practice","PPP","Inclusion Criteria:\n\n* Individuals assigned male at birth who are aged 18 and over and who have capacity to consent\n* Patients who have undergone genetic risk profiling for prostate cancer and have received their results\n* Individuals from diverse backgrounds (age, ethnicity, risk status, etc)\n* Healthcare providers who have delivered a genetic risk profiling result for prostate cancer\n\nExclusion Criteria:\n\n* Individuals who lack capacity to consent\n* Individuals deemed unsuitable to recruit based on their poor performance status or current medical condition",true,"MALE","18 Years","100 Years",{"count":74,"type":75},40,"ESTIMATED","OBSERVATIONAL","A qualitative interview study exploring the patient and provider perspectives on the clinical utility of genetic risk profiling in routine clinical practice. The findings from the study may contribute towards future research and informing clinical practice.",[79],"Prostate Cancer",[81,82,83,79,84,85],"Patients","Providers","Genetic Risk Profiling","Clinical Utility","Perspectives","2026-07-28",{"date":88,"type":89},"2026-08-03","ACTUAL",{"date":91,"type":89},"2026-05-01",{"date":93,"type":75},"2027-08-31",{"name":5,"class":6},1]